Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.428NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.374NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.63 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.377NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.298NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.30.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.120NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.249NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.505NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.406NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.115NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AA.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.178NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.208NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.197NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.491NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.8 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.75.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.56.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used